The use of blind proficiency testing (PT) to examine analytic performance of human immunodeficiency virus type 1 (HIV-1) antibody testing.
A total of 32 hospital, blood bank, public health, and commercial laboratories were included in this study.
Test sera were introduced as clinical specimens for HIV- 1 testing from private practitioners, group practices, clinics, and hospitals in Southern California.
A total of 26 laboratories were located throughout California, with six laboratories located in six other states.
Mots-clés Pascal : Virus immunodéficience humaine, Lentivirinae, Retroviridae, Virus, Evaluation performance, Méthode immunoenzymatique, Sérologie, Etude multicentrique, Virologie, Laboratoire, Biologie clinique, Etats Unis, Amérique du Nord, Amérique, Assurance qualité, Test aveugle, Western blot, Méthode immunoblotting
Mots-clés Pascal anglais : Human immunodeficiency virus, Lentivirinae, Retroviridae, Virus, Performance evaluation, Enzyme immunoassay, Serology, Multicenter study, Virology, Laboratory, Clinical biology, United States, North America, America, Quality assurance, Immunoblotting assay
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0306672
Code Inist : 002B30A01C. Création : 199406.